These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21208168)

  • 21. Amphetamine-type stimulant use among men who have sex with men (MSM) in Vietnam: Results from a socio-ecological, community-based study.
    Vu NT; Holt M; Phan HT; Le HT; La LT; Tran GM; Doan TT; Nguyen TN; de Wit J
    Drug Alcohol Depend; 2016 Jan; 158():110-7. PubMed ID: 26656138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis.
    Vu NT; Maher L; Zablotska I
    J Int AIDS Soc; 2015; 18(1):19273. PubMed ID: 25609214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal.
    Chen PH; Huang MC; Lai YC; Chen PY; Liu HC
    Addict Biol; 2014 May; 19(3):482-5. PubMed ID: 22458544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current situation of substance abuse/dependence in psychiatric hospital settings].
    Ozaki S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Feb; 39(1):35-40. PubMed ID: 15058092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of molecular hydrogen intervention on the gut microbiome in methamphetamine abusers with mental disorder.
    Wang Y; Wang M; Xie B; Wen D; Li W; Zhou M; Wang X; Lu Y; Cong B; Ni Z; Ma C
    Brain Res Bull; 2023 Feb; 193():47-58. PubMed ID: 36516898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for treating methamphetamine, heroin and cocaine use disorders.
    Xiaoshan T; Junjie Y; Wenqing W; Yunong Z; Jiaping L; Shanshan L; Kutty Selva N; Kui C
    Drug Discov Today; 2020 Mar; 25(3):610-619. PubMed ID: 31419495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.
    Itzhak Y; Achat-Mendes C
    IUBMB Life; 2004 May; 56(5):249-55. PubMed ID: 15370888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
    Attarzadeh-Yazdi G; Arezoomandan R; Haghparast A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():142-8. PubMed ID: 24768984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes and consequences of methamphetamine and MDMA toxicity.
    Quinton MS; Yamamoto BK
    AAPS J; 2006 May; 8(2):E337-47. PubMed ID: 16796384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ; McGregor IS; Hunt GE; Cornish JL
    Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic agents in the treatment of methamphetamine dependence.
    Morley KC; Cornish JL; Faingold A; Wood K; Haber PS
    Expert Opin Investig Drugs; 2017 May; 26(5):563-578. PubMed ID: 28351169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Addiction to cocaine and other stimulants].
    Lacoste J; Delavenne-Garcia H; Charles-Nicolas A; Duarte Garcia F; Jehel L
    Presse Med; 2012 Dec; 41(12 Pt 1):1209-20. PubMed ID: 23021656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
    Carroll FI; Abraham P; Gong PK; Pidaparthi RR; Blough BE; Che Y; Hampton A; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2009 Nov; 52(22):7301-9. PubMed ID: 19877685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.
    Curtin K; Fleckenstein AE; Robison RJ; Crookston MJ; Smith KR; Hanson GR
    Drug Alcohol Depend; 2015 Jan; 146():30-8. PubMed ID: 25479916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.